article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment.

Sales 98